Orphenadrine Citrate, Aspirin And Caffeine Tablet
Product Images NDC 71993-304

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate, Aspirin And Caffeine (NDC 71993-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atland Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Capture)

This is a description of a medication called "Orphenadrine Citrate, Aspirin and Caffeine Tablets USP". Each tablet contains 25mg/ 385mg/ 30mg. The usual adult dosage is one to two tablets three to four times a day, and additional literature is available. The tablets come in a bulk package of 607, and should be kept out of reach of children in a light-resistant container. The medication is manufactured for AT L AN D PHARMACEUTICALS and should be stored below 30 degrees Celsius. There are also measurements listed as 2.0000" and R0.1250", but their purpose is not clear.*

FDA Label Image

Structure (Structure1)

This text seems to describe a chemical compound with the molecular formula C,gH,NO*C.HO, and a molecular weight of 461.51. The number 1823 is not related to the description and may be an unrelated error.*

FDA Label Image

Structure1 (Structure2)

FDA Label Image

Structure2 (Structure3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.